drugset / Trial / NCT02372318

Single-dose of Nalmefene to Modulate Neural Alcohol Cue Reactivity

NCT02372318

RandomizedCrossoverTriple-blindBasic science

Summary

The aim of this study is to use functional Magnetic Resonance Imaging (fMRI) to measure neural reactivity to alcohol-related and emotional cues in alcohol dependent subjects following a single dose of the opioid receptor modulator nalmefene. The study will be done in a cross over design with nalmefene versus placebo.

Timeline

Start
2015-04
Primary completion
2016-05
Completion
2016-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Nalmefene Small molecule 18 mg Oral

Indications